首页> 美国卫生研究院文献>Methodist DeBakey Cardiovascular Journal >Fatty Liver: a Link to Cardiovascular Disease – Its Natural History Pathogenesis and Treatment
【2h】

Fatty Liver: a Link to Cardiovascular Disease – Its Natural History Pathogenesis and Treatment

机译:脂肪肝:与心血管疾病的联系-其自然史发病机制和治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in western society and is increasing in parallel with the worldwide epidemic of obesity. It exists in a simple form, steatosis, or a more complex and more dangerous form, steatohepatitis, and it is often but not always associated with the metabolic syndrome. NAFLD can progress to cirrhosis and hepatocellular carcinoma. It is responsible for the majority of cryptogenic cirrhosis cases. Increasingly, NAFLD and its more sinister form, steatohepatitis, have been linked to the increased incidence of cardiovascular disease (CVD) worldwide, independent of the metabolic syndrome. Death from CVD surpasses death from liver complications, but that is beginning to change as people are living longer with CVD. In this article, we will review nonalcoholic fatty liver disease and its epidemiology, prevalence, pathology, and link to CVD.
机译:非酒精性脂肪性肝病(NAFLD)已成为西方社会中最流行的肝病,并且与全世界的肥胖症流行同步上升。它以简单的形式(脂肪变性)或更复杂和更危险的形式(脂肪性肝炎)存在,并且常常但并非总是与代谢综合征相关。 NAFLD可发展为肝硬化和肝细胞癌。它负责大多数隐源性肝硬化病例。 NAFLD及其更险恶的脂肪性肝炎已越来越多地与全世界心血管疾病(CVD)的发生率增加相关,而与代谢综合征无关。 CVD所致的死亡超过了肝脏并发症所致的死亡,但是随着人们CVD寿命的延长,这种情况开始改变。在本文中,我们将回顾非酒精性脂肪肝疾病及其流行病学,患病率,病理学以及与CVD的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号